- Report
- January 2021
- 139 Pages
China, Global
From €3000EUR$3,345USD£2,655GBP
Sugammadex is a neuromuscular blocking agent used in anesthetic drugs. It is a modified gamma-cyclodextrin molecule that binds to and reverses the effects of rocuronium and vecuronium, two commonly used neuromuscular blocking agents. It is used to facilitate rapid recovery from neuromuscular blockade, allowing for a shorter duration of anesthesia and a quicker return to normal activities. Sugammadex is administered intravenously and is available in both a powder and a solution form.
The Sugammadex market is composed of a variety of companies that produce and distribute the drug. These companies include Merck, Fresenius Kabi, Baxter, and Mylan. Additionally, there are several generic manufacturers that produce and distribute the drug. These companies include Teva Pharmaceuticals, Sandoz, and Apotex. Show Less Read more